Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Saber S.; Nasr M.; Kaddah M.M.Y.; Mostafa-Hedeab G.; Cavalu S.; Mourad A.A.E.; Gaafar A.G.A.; Zaghlool S.S.; Saleh S.; Hafez M.M.; Girgis S.; Elgharabawy R.M.; Nader K.; Alsharidah M.; Batiha G.E.-S.; El-Ahwany E.; Amin N.A.; Elagamy H.I.; Shata A.; Nader R.; Khodir A.E.

Journal: Biomedicine and Pharmacotherapy

Publisher: Elsevier Masson s.r.l.

Publication Date: April 2022

Volume / Issue: Volume 148

Article No.: 112731

ISSN: 7533322

DOI: 10.1016/j.biopha.2022.112731

Scopus: View on Scopus

PubMed: 35220029

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Saber S., Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt; Nasr M., Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Helwan University, Cairo, 11790, Egypt, Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt; Kaddah M.M.Y., Pharmaceutical and Fermentation Industries Development Center, City of Scientific Research and Technological Applications, Alexandria, New Borg El-Arab, 21934, Egypt; Mostafa-Hedeab G., Pharmacology Department & Health Research Unit, Medical College, Jouf University, Saudi Arabia, Pharmacology Department, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt; Cavalu S., Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, Oradea, 410087, Romania; Mourad A.A.E., Department of Pharmacology and Toxicology, Faculty of Pharmacy, Port Said University, Port Said, 42511, Egypt; Gaafar A.G.A., Department of Pharmacology and Toxicology, Faculty of Pharmacy, Port Said University, Port Said, 42511, Egypt; Zaghlool S.S., Pharmacology and Toxicology Department, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Mokattam, Cairo, 11571, Egypt; Saleh S., Department of Clinical Physiology, Faculty of Medicine, Menoufia University, Menoufia, Egypt; Hafez M.M., Department of Biochemistry, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt; Girgis S., Department of Pharmaceutics, Faculty of Pharmacy, Alsalam University, Egypt; Elgharabawy R.M., Pharmacology and Toxicology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Nader K., Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt; Alsharidah M., Department of Physiology, College of Medicine, Qassim University, Qassim, 51452, Saudi Arabia; Batiha G.E.-S., Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, AlBeheira, Damanhour, 22511, Egypt; El-Ahwany E., Department of Immunology, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Amin N.A., Department of Haematology, Theodor Bilharz Research Institute, Giza, 12411, Egypt; Elagamy H.I., Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt; Shata A., Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt, Department of Clinical Pharmacy, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt; Nader R., Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt; Khodir A.E., Department of Pharmacology, Faculty of Pharmacy, Horus University, New Damietta, Egypt


Abstract

Pulmonary fibrosis (PF) is a chronic progressive disease that portends a very poor prognosis. It has been suggested that STAT3 is a potential target in PF. This study highlights the importance of cubosomes as a drug delivery system in enhancing the bioavailability of nifuroxazide (NXZD), a poorly soluble STAT3 inhibitor. NXZD-loaded cubosomes (NXZD-LC) were in vitro and in vivo evaluated. In vitro, cubosomes presented a poly-angular nanosized particles with a mean size and zeta potential of 223.73 ± 4.73 nm and − 20.93 ± 2.38 mV, respectively. The entrapment efficiency of nifuroxazide was 90.56 ± 4.25%. The in vivo pharmacokinetic study and the lung tissue accumulation of NXZD were performed by liquid chromatography-tandem mass spectrometry after oral administration to rats. The nanoparticles exhibited a two-fold increase and 1.33 times of bioavailability and lung tissue concentration of NXZD compared to NXZD dispersion, respectively. In view of this, NXZD-LC effectively attenuated PF by targeting STAT3 and NF-κB signals. As a result, NXZD-LC showed a potential anti-inflammatory effect as revealed by the significant decrease in MCP-1, ICAM-1, IL-6, and TNF-α and suppressed fibrogenic mediators as indicated by the significant reduction in TGF-β, TIMP-1, and PDGF-BB in lung tissues. Besides, NXZD-LC improved antioxidant defense mechanisms and decreased LDH and BALF total protein. These effects contributed to decreased collagen deposition. To conclude, cubosomes represent an advantageous pharmaceutical delivery system for enhancing pulmonary delivery of poorly soluble drugs. Additionally, repurposing NXZD as an antifibrotic agent is a promising challenge and new therapeutic approach for unmet therapeutic needs. © 2022 The Authors


Keywords

Bleomycin-induced lung fibrosis; Cubosomes; LC-MS/MS; NF-κB; Nifuroxazide; Pharmacokinetics; Pulmonary delivery; STAT3; Administration, Oral; Animals; Anti-Inflammatory Agents; Antifibrotic Agents; Biological Availability; Bleomycin; Drug Delivery Systems; Hydroxybenzoates; Lung; Male; Nanoparticles; NF-kappa B; Nitrofurans; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; antifibrotic agent; antioxidant; collagen; cubosome; eosin; hematoxylin; hydroxyproline; immunoglobulin enhancer binding protein; intercellular adhesion molecule 1; interleukin 6; lactate dehydrogenase; malonaldehyde; monocyte chemotactic protein 1; nanoparticle; nitrate; nitrite; platelet derived growth factor BB; secobarbital; STAT3 protein; superoxide dismutase; tissue inhibitor of metalloproteinase 1; toll like receptor 4; transcription factor RelA; transforming growth factor beta; tumor necrosis factor; unclassified drug; antiinflammatory agent; hydroxybenzoic acid derivative; nitrofuran derivative; adult; animal experiment; animal model; animal tissue; antiinflammatory activity; area under the curve; Article; bicinchoninic acid assay; binding affinity; bioavailability; bleomycin-induced pulmonary fibrosis; bronchoalveolar lavage fluid; colorimetry; controlled study; drug delivery system; enzyme activity; enzyme linked immunosorbent assay; flow rate; histology; histopathology; leukocyte differential count; liquid chromatography-mass spectrometry; NF kB signaling; nonhuman; oxidative stress; particle size; protein content; quality control; rat; real time reverse transcription polymerase chain reaction; single drug dose; spectrophotometry; transmission electron microscopy; zeta potential; animal; chemistry; drug effect; lung fibrosis; metabolism; oral drug administration; pathology; pharmacology; procedures; Sprague Dawley rat


Citation Information

Scopus Citations: 28


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]